Need Help?

Human tumor ChIP-seq.

We profiled 15 patient brain tumor samples by ChIP-seq. Inputs are provided for 16 samples, H3K27ac is provided for 15 samples, H3K27me3 is provided for 10 samples and H3K27me3 is provided for 5 samples. The raw bam files are provided.

Request Access

Access to data generated by our group is available by emailing application to the data access committee and will be granted to qualified investigators for appropriate use. For further guidelines, application form and data access agreement.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom the Research Institute of the McGill University Health Centre (RI-MUHC) grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: RI-MUHC and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. Provider Institution: The Research Institute of the McGill University Health Centre (RI-MUHC) 2155 Guy Street, Suite 500 Montreal, Quebec, CANADA H3H 2L9 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines ( http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/w eb_document/wtd003207.pdf ) and the Toronto Statement ( http://www.nature.com/nature/journal/v461/n7261/full/461168a.html ). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) ( https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) ( http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the RI-MUHC within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the RI-MUHC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the RI-MUHC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. the RI-MUHC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the RI-MUHC. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005773 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005718595 bam 3.4 GB
EGAF00005718602 bam 3.4 GB
EGAF00005718603 bam 4.1 GB
EGAF00005718606 bam 7.8 GB
EGAF00005718607 bam 1.4 GB
EGAF00005718608 bam 1.1 GB
EGAF00005718609 bam 4.2 GB
EGAF00005718610 bam 2.5 GB
EGAF00005718611 bam 4.6 GB
EGAF00005718624 bam 3.9 GB
EGAF00005718627 bam 9.7 GB
EGAF00005718632 bam 3.6 GB
EGAF00005718633 bam 4.3 GB
EGAF00005718636 bam 1.2 GB
EGAF00005718637 bam 7.0 GB
EGAF00005718654 bam 7.5 GB
EGAF00005718655 bam 13.0 GB
EGAF00005718662 bam 1.6 GB
EGAF00005718667 bam 1.4 GB
EGAF00005718670 bam 2.2 GB
EGAF00005718671 bam 3.9 GB
EGAF00005718672 bam 3.1 GB
EGAF00005718673 bam 2.3 GB
EGAF00005718676 bam 2.7 GB
EGAF00005718677 bam 3.1 GB
EGAF00005718678 bam 2.2 GB
EGAF00005718679 bam 2.3 GB
EGAF00005718682 bam 980.8 MB
EGAF00005718685 bam 7.0 GB
EGAF00005718688 bam 1.4 GB
EGAF00005718693 bam 2.4 GB
EGAF00005718696 bam 6.0 GB
EGAF00005718701 bam 10.9 GB
EGAF00005718702 bam 3.1 GB
EGAF00005718703 bam 2.8 GB
EGAF00005718708 bam 1.8 GB
EGAF00005718709 bam 3.1 GB
EGAF00005718710 bam 2.7 GB
EGAF00005718725 bam 3.2 GB
EGAF00005718730 bam 6.9 GB
EGAF00005718733 bam 1.0 GB
EGAF00005718736 bam 870.1 MB
EGAF00005718741 bam 1.4 GB
EGAF00005718742 bam 4.9 GB
EGAF00005718743 bam 3.0 GB
EGAF00005718756 bam 2.4 GB
EGAF00005718763 bam 5.1 GB
EGAF00005718766 bam 3.5 GB
EGAF00005718767 bam 1.5 GB
EGAF00005718768 bam 2.9 GB
EGAF00005718769 bam 1.6 GB
EGAF00005718770 bam 2.7 GB
52 Files (190.7 GB)